ArticleExpert review of clinical pharmacology2020

Could a specific ACE2 activator drug improve the clinical outcome of SARS-CoV-2? A potential pharmacological insight.

Lucas A D Nicolau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.